Clinical Trial Update: Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract [Phase 2]

View source ↗

Summary

Phase 2 dose-response trial evaluating subcutaneous immunotherapy with a standardized Dermatophagoides pteronyssinus extract for allergic rhinoconjunctivitis ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis

Drugs mentioned

• Dermatophagoides pteronyssinus extract (Dermatophagoides pteronyssinus extract)

Snippet

Sponsor: Roxall Medicina España S.A | Conditions: Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED